Nicotinell Menthe Fraicheur Sans Sucre (Nicotine Polacrilex)

Nicotine polacrilex is a polymer‑bound nicotine complex that releases nicotine slowly when placed against the buccal mucosa. The nicotine is absorbed through the oral lining, stimulating nicotinic acetylcholine receptors in the brain, which mimics the effect of cigarette‑derived nicotine and eases withdrawal.

The specific dose and regimen are determined by the prescribing healthcare professional based on the individual’s smoking history, level of dependence, and treatment goals. Patients should follow the prescriber’s instructions and the product label.

Safety in pregnancy and lactation has not been fully established. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using this product.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Nicotinell delivers nicotine via a buccal polymer complex, offering a slower, more controlled release compared with traditional nicotine gum or lozenges. This can result in steadier plasma nicotine levels and may reduce the frequency of dosing, but individual preference and tolerability vary.

Store the product below 25 °C in its original packaging, protecting it from moisture, heat and direct sunlight. Do not refrigerate or freeze the tablets, as extreme temperatures may affect the polymer matrix and nicotine release profile.

The tablet is placed between the gum and cheek (buccal cavity) and allowed to dissolve slowly. Users should avoid chewing or swallowing the tablet whole, and should not eat or drink for several minutes after placement to ensure optimal nicotine absorption.

Serious risks include allergic reactions such as rash, swelling or difficulty breathing, and rare oral ulceration. If any signs of an allergic response or severe oral irritation occur, discontinue use and seek immediate medical attention.

Individuals with known hypersensitivity to nicotine polacrilex or any excipients, those using other nicotine replacement products simultaneously, and patients with uncontrolled cardiovascular disease should avoid this product unless directed otherwise by a healthcare professional.